☆ 4.5 Article

Endometrial carcinosarcoma

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

添加到收藏夹

Article Oncology

Clear cell carcinoma of the endometrium

Giorgio Bogani et al.

Summary: Clear cell endometrial carcinoma is a rare and poorly understood cancer type. Genetic profiling can assess prognosis, with most patients characterized by p53 abnormality or NSMP type. Patients with POLE mutation have a good prognosis, while chemotherapy is effective for NSMP and p53 abnormal patients. MMRd patients may not benefit from chemotherapy, and immune checkpoint inhibitors may be more suitable for them. Further clinical trials are needed to clarify the treatment strategies for clear cell endometrial carcinoma.

GYNECOLOGIC ONCOLOGY (2022)

添加到收藏夹

Article Oncology

ADAGIO: a phase IIb international study of the Wee1 inhibitor adavosertib in women with recurrent or persistent uterine serous carcinoma

Joyce Liu et al.

Summary: Uterine serous carcinoma is a challenging histologic subtype with limited treatment options. A trial is underway to evaluate the efficacy of the Wee1 inhibitor adavosertib in women with recurrent or persistent uterine serous carcinoma, with an estimated completion date of the end of 2022 and approximately 120 patients enrolled in the study.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

添加到收藏夹

Review Obstetrics & Gynecology

Uterine carcinosarcoma vs endometrial serous and clear cell carcinoma: A systematic review and meta-analysis of survival

Antonio Raffone et al.

Summary: A systematic review and meta-analysis showed that compared to SC and CCC, UCS has a significantly worse prognosis with a 1.5-1.6-fold increased risk of death. This suggests the need for more aggressive treatment for UCS compared to SC and CCC. Further studies are necessary to define the prognostic impact of different molecular subgroups.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2022)

添加到收藏夹

Article Oncology

Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study

David M. O'Malley et al.

Summary: Pembrolizumab demonstrated durable antitumor activity and encouraging survival outcomes in previously treated patients with MSI-H/dMMR endometrial cancer.

JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial

Matthew A. Powell et al.

Summary: This phase III randomized trial compared the efficacy of paclitaxel and carboplatin (PC) with paclitaxel and ifosfamide (PI) in the treatment of uterine carcinosarcoma. The results showed that PC was not inferior to PI and should be considered as the standard treatment for uterine carcinosarcoma.

JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

V Makker et al.

Summary: Lenvatinib plus pembrolizumab significantly prolongs progression-free survival and overall survival compared to chemotherapy in advanced endometrial cancer patients.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Oncology

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET - a phase I, single-arm study

Ana Oaknin et al.

Summary: Dostarlimab demonstrated durable antitumor activity in patients with endometrial cancer, with a manageable safety profile.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

添加到收藏夹

Review Obstetrics & Gynecology

Prognostic value of the TCGA molecular classification in uterine carcinosarcoma

Antonio Travaglino et al.

Summary: The study included five studies with 263 UCS, indicating that POLEmut UCS have an excellent prognosis, while TP53mut/p53abn and NSMP UCS have a prognosis even worse than that of TP53mut/p53abn endometrioid/serous carcinomas. The prognosis of MSI/MMRd UCS remains to be defined.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2022)

添加到收藏夹

Article Oncology

Sentinel lymph node biopsy alone compared to systematic lymphadenectomy in patients with uterine carcinosarcoma

William A. Zammarrelli et al.

Summary: This study compared the survival rates of CS patients who underwent SLN biopsy with those who underwent systematic LND and found no difference in PFS or OS. SLN biopsy can detect nodal metastasis without compromising oncologic outcomes.

GYNECOLOGIC ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Molecular profiles of endometrial cancer tumors among Black patients

Annelise M. Wilhite et al.

Summary: There are disparate molecular profiles between Black and White patients with endometrial cancer, primarily driven by histologic differences. This study emphasizes the importance of including Black patients and other under-represented populations in molecular profiling studies of endometrial cancer as targeted therapies and personalized medicine become more common.

GYNECOLOGIC ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Evaluating long-term outcomes of three approaches to retroperitoneal staging in endometrial cancer

Giorgio Bogani et al.

Summary: This study evaluated the long-term survival of three different approaches of nodal assessment in endometrial cancer patients and found that sentinel lymph node mapping (SNM) provides similar long-term oncologic outcomes to lymphadenectomy (LND).

GYNECOLOGIC ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Effectiveness of Intensive Versus Minimalist Follow-Up Regimen on Survival in Patients With Endometrial Cancer (TOTEM Study): A Randomized, Pragmatic, Parallel Group, Multicenter Trial

Paolo Zola et al.

Summary: The TOTEM study conducted a randomized trial on intensive versus minimalist follow-up regimens in endometrial cancer-treated patients. The study found that intensive follow-up did not improve overall survival rates, even in high-risk patients. Routine addition of vaginal cytology, laboratory, or imaging investigations is unnecessary according to the results of this trial.

JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Endometrial Cancer: Transitioning from Histology to Genomics

Cristina Mitric et al.

Summary: Endometrial carcinoma can be classified into four molecular groups, which can assist in clinical decision-making for adjuvant treatment. This classification has implications for clinical trials and exploring novel treatments.

CURRENT ONCOLOGY (2022)

添加到收藏夹

Article Obstetrics & Gynecology

Immunohistochemical Markers With Potential Diagnostic, Prognostic, and Therapeutic Significance in Uterine Carcinosarcoma: A Clinicopathologic Study of 43 Cases

Terrell E. Jones et al.

Summary: Uterine carcinosarcomas (UCS) are rare and highly aggressive tumors with distinct immunohistochemical characteristics. The expression of PDL-1, PAX-8, and estrogen receptor showed significant differences between epithelial and stromal components, while p53 expression was associated with clinical high stage. Other markers did not correlate with stage or survival.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2021)

添加到收藏夹

Article Oncology

Patterns of failure after adjuvant sandwich chemo-radio-chemotherapy in locally advanced (stage III-IVA) endometrial cancer

Francesco Raspagliesi et al.

Summary: Adjuvant sandwich chemo-radio-chemotherapy shows promising local and loco-regional control for locally advanced endometrial cancer, but distant failure rate is high. Positive peritoneal cytology is associated with increased risk of recurrence. More systemic treatment strategies may be needed for these patients.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Nicole Concin et al.

Summary: The European consensus conference on endometrial carcinoma in 2014 aimed to produce multi-disciplinary evidence-based guidelines. Since then, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) have decided to update the guidelines and cover new topics to improve care for women with endometrial carcinoma globally.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

添加到收藏夹

Review Oncology

Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis

Jutta Huvila et al.

Summary: Endometrial carcinoma has various morphological variants with distinct molecular abnormalities. Early diagnosis of the rare recognized precursor lesions is crucial for the relatively favorable prognosis of EC.

JOURNAL OF PATHOLOGY (2021)

添加到收藏夹

Article Oncology

European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma

Nicole Concin et al.

Summary: This study developed 29 quality indicators (QIs) for the surgical management of endometrial cancer, covering aspects including center case load, multidisciplinary team structure, and clinical research participation. A scoring system was created to ensure feasibility for future ESGO accreditation of centers for endometrial cancer surgery.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

添加到收藏夹

Review Oncology

Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity

Shinya Matsuzaki et al.

Summary: Uterine carcinosarcoma is an aggressive high-grade endometrial cancer with increasing incidence. Multimodal treatment is the mainstay, but survival outcomes remain dismal.

GYNECOLOGIC ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Uterine serous carcinoma

Giorgio Bogani et al.

Summary: Serous endometrial cancer is rare but has high mortality rate, presenting challenges in treatment. Currently, combination therapies and clinical trials are crucial in managing this difficult disease.

GYNECOLOGIC ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Sequencing chemotherapy before radiotherapy for women with stage IIIC endometrial cancer

Deepa Maheswari Narasimhulu et al.

Summary: The study showed that for stage IIIC endometrial cancer, sequencing chemotherapy before radiation increased the completion rate of chemotherapy cycles and reduced locoregional lymphatic recurrence, despite delaying radiotherapy until after 3-6 cycles of chemotherapy and not administering concurrent cisplatin. Additionally, the number of chemotherapy cycles before radiotherapy was found to impact distant recurrence rates in endometrial cancer trials.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

添加到收藏夹

Article Medicine, General & Internal

Molecular Landscape of the Epithelial-Mesenchymal Transition in Endometrioid Endometrial Cancer

Marcin Oplawski et al.

Summary: Modern diagnostics focus on molecular analysis and the search for new molecular markers. This study evaluated the differences in mRNA and miRNA expression related to endometrial cancer grades, aiming to select promising molecular markers. The analysis identified potential diagnostic markers associated with epithelial-mesenchymal transition.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Meeting Abstract Oncology

Efficacy and safety of trastuzumab deruxtecan in HER2-expressing uterine carcinosarcoma (STATICE trial, NCCH1615): A multicenter, phase II clinical trial

K. Hasegawa et al.

ANNALS OF ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Uterine carcinosarcoma: An overview

Gaetano Pezzicoli et al.

Summary: Uterine carcinosarcoma, also known as malignant mixed M & uuml;llerian tumor, is a rare gynecological malignancy with poor prognosis. Surgical resection is the best curative option for localized disease, and additional peri-operative treatments have been shown to improve outcomes. Palliative chemotherapy is the treatment of choice for metastatic disease, with no consensus on the best regimen.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

添加到收藏夹

Review Oncology

Uterine carcinosarcomas: From pathology to practice

Michael D. Toboni et al.

Summary: The review summarized the latest research and clinical trial data on uterine carcinosarcoma, highlighting the lack of evidence for early-stage disease treatment and the valuable information provided by recent results from GOG 261 for treatment strategies, indicating potential use of more targeted agents for UCS in the future.

GYNECOLOGIC ONCOLOGY (2021)

添加到收藏夹

Review Genetics & Heredity

Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms

Seiichi Mori et al.

Summary: Gynecological malignancies have various histological subtypes, each reflecting the cell of origin and closely linked to clinical behavior and biological phenotype of the tumor. Advances in massive parallel sequencing have provided a comprehensive view of genomic alterations in individual tumors, highlighting driver-gene mutations and molecular subtypes associated with specific histotypes. Large genomic datasets, such as the Cancer Genome Atlas, have been crucial in identifying clinically relevant targets and biomarkers, and in characterizing genomes, driver mutations, and histotypes of even rare cancer types.

JOURNAL OF HUMAN GENETICS (2021)

添加到收藏夹

Article Oncology

NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021

Nadeem R. Abu-Rustum et al.

Journal of the National Comprehensive Cancer Network (2021)

添加到收藏夹

Article Oncology

Carcinosarcomas of the Uterus: Prognostic Factors and Impact of Adjuvant Treatment

Kerri Beckmann et al.

Summary: Analysis of multi-institutional clinical registry data from South Australia suggests that UCS patients benefit from nodal excision, chemotherapy, and multimodal therapy in terms of reducing disease-specific and all-cause mortality, particularly in late-stage disease. However, caution is warranted in interpreting the results due to potential indication bias and limited statistical power, underscoring the need for further prospective research.

CANCER MANAGEMENT AND RESEARCH (2021)

添加到收藏夹

Article Oncology

Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel

Yusuke Kobayashi et al.

Summary: This study aimed to categorize endometrial cancers with solid proliferation according to TCGA classification using a small custom-made cancer genome panel. Integration of IHC and NGS analysis may be a practical diagnostic tool for endometrial cancers.

PATHOLOGY & ONCOLOGY RESEARCH (2021)

添加到收藏夹

Article Oncology

HDAC Inhibition Induces Cell Cycle Arrest and Mesenchymal-Epithelial Transition in a Novel Pleural-Effusion Derived Uterine Carcinosarcoma Cell Line

Paul Stockhammer et al.

Summary: A novel UCS cell line (PF338) was established, demonstrating resistance to MEK- and TGF-beta signaling-inhibition but sensitivity to PIK3CA- and PARP-inhibition and first-line chemotherapeutics. Histone deacetylase (HDAC) inhibition markedly reduced cell viability, inducing mesenchymal-epithelial transition in UCS cells.

PATHOLOGY & ONCOLOGY RESEARCH (2021)

添加到收藏夹

Article Oncology

Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study

Nilofer S. Azad et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway

Maria M. Rubinstein et al.

CANCER (2020)

添加到收藏夹

Article Oncology

Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)

Neesha C. Dhani et al.

CLINICAL CANCER RESEARCH (2020)

添加到收藏夹

Article Medicine, Research & Experimental

S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma

Masataka Tochimoto et al.

LABORATORY INVESTIGATION (2020)

添加到收藏夹

Article Oncology

Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma

Jennifer McEachron et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

添加到收藏夹

Article Oncology

Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis

Amanda N. Fader et al.

CLINICAL CANCER RESEARCH (2020)

添加到收藏夹

Article Oncology

Pembrolizumab and Radiotherapy for Platinum-refractory Recurrent Uterine Carcinosarcoma With an Abscopal Effect: A Case Report

Mitsutake Yano et al.

ANTICANCER RESEARCH (2020)

添加到收藏夹

Article Oncology

Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study

Willem Jan van Weelden et al.

EUROPEAN JOURNAL OF CANCER (2020)

添加到收藏夹

Review Medicine, General & Internal

Endometrial Cancer

Karen H. Lu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Meeting Abstract Oncology

SENTINEL LYMPH NODE BIOPSY VERSUS LYMPHADENECTOMY FOR INTERMEDIATE AND HIGH GRADE ENDOMETRIAL CANCER STAGING (SENTOR TRIAL): A PROSPECTIVE MULTICENTER COHORT STUDY

M. Cusimano et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

添加到收藏夹

Article Medicine, General & Internal

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer

Daniela Matei et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Oncology

Neoadjuvant Chemoradiation Therapy Followed by Extrafascial Hysterectomy in Locally Advanced Type II Endometrial Cancer Clinically Extending to Cervix

Uzoma K. Iheagwara et al.

PRACTICAL RADIATION ONCOLOGY (2019)

添加到收藏夹

Article Pathology

Histologic Appearance and Immunohistochemistry of DNA Mismatch Repair Protein and p53 in Endometrial Carcinosarcoma Impact on Prognosis and Insights Into Tumorigenesis

Masayuki Saijo et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma

Osamu Gotoh et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Article Oncology

Prognostic factors impacting survival in early stage uterine carcinosarcoma

Katherine C. Kurnit et al.

GYNECOLOGIC ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma

Jillian R. Gunther et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)

添加到收藏夹

Article Oncology

Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery

Koji Matsuo et al.

JOURNAL OF SURGICAL ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Tumor Mutational Burden Guides Therapy in a Treatment Refractory POLE-Mutant Uterine Carcinosarcoma

Munveer S. Bhangoo et al.

ONCOLOGIST (2018)

添加到收藏夹

Article Oncology

Lymphadenectomy and Adjuvant Therapy Improve Survival with Uterine Carcinosarcoma: A Large Retrospective Cohort Study

Marco A. C. Versluis et al.

ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma Patterns of Care and Impact on Overall Survival

Bismarck Odei et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)

添加到收藏夹

Article Oncology

Patterns of Adjuvant Therapy Utilization in Uterine Carcinosarcoma Stages I to III A National Cancer Database Analysis

William A. Stokes et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)

添加到收藏夹

Article Oncology

Improved survival with adjuvant brachytherapy in stage IA endometrial cancer of unfavorable histology

Ashwin Shinde et al.

GYNECOLOGIC ONCOLOGY (2018)

添加到收藏夹

Article Oncology

A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus, an NRG Oncology/Gynecologic Oncology Group study

Carolyn K. McCourt et al.

GYNECOLOGIC ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Stage I uterine carcinosarcoma: Matched cohort analyses for lymphadenectomy, chemotherapy, and brachytherapy

Brandon-Luke L. Seagle et al.

GYNECOLOGIC ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma

Koji Matsuo et al.

GYNECOLOGIC ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Distinct molecular landscapes between endometrioid and nonendometrioid uterine carcinomas

Nathaniel L. Jones et al.

INTERNATIONAL JOURNAL OF CANCER (2017)

添加到收藏夹

Article Oncology

Use of Adjuvant Chemotherapy, Radiation Therapy, or Combined Modality Therapy and the Impact on Survival for Uterine Carcinosarcoma Limited to the Pelvis

Andrew T. Wong et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)

添加到收藏夹

Article Oncology

Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study

Patrick A. Ott et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Confirmation of ProMisE: A Simple, Genomics-Based Clinical Classifier for Endometrial Cancer

Aline Talhouk et al.

CANCER (2017)

添加到收藏夹

Article Oncology

Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping

Maria B. Schiavone et al.

ANNALS OF SURGICAL ONCOLOGY (2016)

添加到收藏夹

Article Oncology

Adjuvant radiation therapy in uterine carcinosarcoma: A population-based analysis of patient demographic and clinical characteristics, patterns of care and outcomes

Julia Manzerova et al.

GYNECOLOGIC ONCOLOGY (2016)

添加到收藏夹

Article Oncology

Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7)

Philipp Harter et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)

添加到收藏夹

Article Oncology

The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma A Multi-institutional Study

David M. Guttmann et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)

添加到收藏夹

Article Oncology

Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08)

Jihye Cha et al.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2016)

添加到收藏夹

Article Oncology

Evaluation of brachytherapy and external beam radiation therapy for early stage, node-negative uterine carcinosarcoma

Nirav Patel et al.

BRACHYTHERAPY (2015)

添加到收藏夹

Article Oncology

Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: A National Cancer Database analysis

J. Alejandro Rauh-Hain et al.

GYNECOLOGIC ONCOLOGY (2015)

添加到收藏夹

Article Oncology

A multi-institutional study of outcomes in stage I-III uterine carcinosarcorna

Elizabeth L. Dickson et al.

GYNECOLOGIC ONCOLOGY (2015)

添加到收藏夹

Article Oncology

Adjuvant Treatment Modalities, Prognostic Predictors and Outcomes of Uterine Carcinosarcomas

Kemal Gungorduk et al.

CANCER RESEARCH AND TREATMENT (2015)

添加到收藏夹

Article Pathology

In-depth molecular profiling of the biphasic components of uterine carcinosarcomas

Melissa K. McConechy et al.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2015)

添加到收藏夹

Article Oncology

A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: A study of the Princess Margaret, Chicago and California Consortia

Vincent Castonguay et al.

GYNECOLOGIC ONCOLOGY (2014)

添加到收藏夹

Article Oncology

A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group study

Susana M. Campos et al.

GYNECOLOGIC ONCOLOGY (2014)

添加到收藏夹

Review Oncology

Review literature on uterine carcinosarcoma

Rajendra Singh

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2014)

添加到收藏夹

Article Oncology

A population-based series of uterine carcinosarcomas with long-term follow-up

Bengt Sorbe et al.

ACTA ONCOLOGICA (2013)

添加到收藏夹

Article Oncology

Phase II trial of combination bevacizumab and temsirolimus in the treatment of A recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study

Edwin A. Alvarez et al.

GYNECOLOGIC ONCOLOGY (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Integrated genomic characterization of endometrial carcinoma

Gad Getz et al.

NATURE (2013)

添加到收藏夹

Article Oncology

A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia

H. J. Mackay et al.

GYNECOLOGIC ONCOLOGY (2012)

添加到收藏夹

Article Oncology

A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: A Gynecologic Oncology Group study

D. Scott McMeekin et al.

GYNECOLOGIC ONCOLOGY (2012)

添加到收藏夹

Article Oncology

Iniparib plus paclitaxel and carboplatin as initial treatment of advanced or recurrent uterine carcinosarcoma: A Gynecologic Oncology Group Study

Carol Aghajanian et al.

GYNECOLOGIC ONCOLOGY (2012)

添加到收藏夹

Article Oncology

Phase II trial of adjuvant pelvic radiation sandwiched between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma

Mark H. Einstein et al.

GYNECOLOGIC ONCOLOGY (2012)

添加到收藏夹

Article Oncology

A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma

Leigh A. Cantrell et al.

GYNECOLOGIC ONCOLOGY (2012)

添加到收藏夹

Article Oncology

The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma

Edward J. Tanner et al.

GYNECOLOGIC ONCOLOGY (2011)

添加到收藏夹

Article Oncology

In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma

K. El-Sahwi et al.

BRITISH JOURNAL OF CANCER (2010)

添加到收藏夹

Article Oncology

A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: A gynecologic oncology group study

Brigitte E. Miller et al.

GYNECOLOGIC ONCOLOGY (2010)

添加到收藏夹

Article Oncology

Efficacy and safety of imatinib mesylate (Gleevec®) and immunohistochemical expression of c-Kit and PDGFR-β in a Gynecologic Oncology Group Phase II Trial in women with recurrent or persistent carcinosarcomas of the uterus

Warner K. Huh et al.

GYNECOLOGIC ONCOLOGY (2010)

添加到收藏夹

Article Oncology

A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II Consortia

Halla S. Nimeiri et al.

GYNECOLOGIC ONCOLOGY (2010)

添加到收藏夹

Article Oncology

Phase II Evaluation of Paclitaxel and Carboplatin in the Treatment of Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

Matthew A. Powell et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

添加到收藏夹

Article Oncology

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study

Howard D. Homesley et al.

GYNECOLOGIC ONCOLOGY (2009)

添加到收藏夹

Article Oncology

Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas

Suzanne George et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

添加到收藏夹

Article Obstetrics & Gynecology

The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma

Jason D. Wright et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)

添加到收藏夹

Article Oncology

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II:: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)

N. S. Reed et al.

EUROPEAN JOURNAL OF CANCER (2008)

添加到收藏夹

Article Oncology

A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma

Vicky Makker et al.

GYNECOLOGIC ONCOLOGY (2008)

添加到收藏夹

Article Oncology

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus

Aaron H. Wolfson et al.

GYNECOLOGIC ONCOLOGY (2007)

添加到收藏夹

Article Oncology

Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: A Gynecologic Oncology Group study

Howard D. Homesley et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

添加到收藏夹

Article Oncology

Phase II trial of thalidomide for advanced and recurrent gynecologic sarcoma: A brief communication from the New York Phase II consortium

DYS Kuo et al.

GYNECOLOGIC ONCOLOGY (2006)

添加到收藏夹

Article Oncology

Phase II evaluation of topotecan in carcinosarcoma of the uterus: A Gynecologic Oncology Group study

DS Miller et al.

GYNECOLOGIC ONCOLOGY (2005)

添加到收藏夹

Article Oncology

On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus

KE Dusenbery et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2005)

添加到收藏夹

Article Oncology

Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study

G Sutton et al.

GYNECOLOGIC ONCOLOGY (2005)

添加到收藏夹

Article Oncology

Malignant mixed Mullerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcome

M Callister et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)

添加到收藏夹

Article Oncology

A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed mullerian tumors with evaluation of potential molecular targets

LM Ramondetta et al.

GYNECOLOGIC ONCOLOGY (2003)

添加到收藏夹

Article Oncology

Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)

REN van Rijswijk et al.

EUROPEAN JOURNAL OF CANCER (2003)

添加到收藏夹

Article Oncology

Paclitaxel in the treatment of carcinosarcoma of the uterus: A gynecologic oncology group study

JP Curtin et al.

GYNECOLOGIC ONCOLOGY (2001)

添加到收藏夹

Article Oncology

Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk population

T Le

EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2001)

添加到收藏夹

Article Oncology

A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A gynecologic oncology group study

G Sutton et al.

GYNECOLOGIC ONCOLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.